Barclays Maintains Teladoc Health(TDOC.US) With Buy Rating, Maintains Target Price $10
Teladoc COO Michael Waters Resigns
Teladoc (TDOC) Stock Sinks As Market Gains: Here's Why
'Lawmakers Push To Let Telehealth Providers Keep Prescribing Stimulants And Addiction Treatment; Flexibility Allowed During Pandemic Is Set To Expire At Year-End' - STAT News
Truist Financial Maintains Teladoc Health(TDOC.US) With Hold Rating
Truist Financial analyst Jailendra Singh maintains $Teladoc Health(TDOC.US)$ with a hold rating.According to TipRanks data, the analyst has a success rate of 35.6% and a total average return of -14.5%
Q2 Earnings Highs And Lows: Teladoc (NYSE:TDOC) Vs The Rest Of The Online Marketplace Stocks